A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
Clinical trial NCT01322490 · COMPLETED
Trial details
- NCT number
- NCT01322490
- Sponsor
- Bavarian Nordic
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-28
- Primary completion
- 2017-09-25
- Enrollment
- 1297
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.